Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis-Reference-Cited by-同舟云学术

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis

Published:2009-02-23 Issue:6 Volume:18 Page:437-447
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Habib Zeina A.,Tzogias Leonidas,Havstad Suzanne L.,Wells Karen,Divine George,Lanfear David E.,Tang Jeffrey,Krajenta Richard,Pladevall Manel,Williams L. Keoki

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference54 articles.

1. Liver enzyme monitoring in patients treated with troglitazone;Graham;JAMA,2001

2. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007

3. Saul S Harris G Diabetes drug still has risks, doctors warn 2007

4. Rosiglitazone: seeking a balanced perspective;Lancet,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Pioglitazone With Major Adverse Cardiovascular Events, All-Cause Mortality, and Heart Failure Hospitalizations: A Systematic Review;Cureus;2023-10-12

2. Thiazolidinediones for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2023-09-07

3. Surface Functionalized Magnetic Nanoparticles as a Selective Sorbent for Affinity Fishing of PPAR-γ Ligands from Choerospondias axillaris;Molecules;2022-05-13

4. Molecular toxicological alterations in the mouse hearts induced by sub‐chronic thiazolidinedione drugs administration;Fundamental & Clinical Pharmacology;2021-05-25

5. Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial;Drug Safety;2018-04-30